Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 91 results.
User Information
Export Records
  1. 1.   Repeated horizontal acquisition of lagriamide-producing symbionts in Lagriinae beetles
  2. Uppal, Siddharth; Simonson,Sam Waterworth; Nick, Alina; Vogel, Heiko; Flórez, Laura V; Kaltenpoth, Martin; Kwan, Jason C
  3. The ISME Journal. 2024, Oct 23;
  1. 2.   The Degradation of Botulinum Neurotoxin Light Chains Using PROTACs
  2. Tsai,Yien Che; Kozar, Loren; Mawi, Zo P; Ichtchenko, Konstantin; Shoemaker, Charles B; McNutt, Patrick M; Weissman,Allan
  3. International Journal of Molecular Sciences. 2024, Jul 08; 25(13):
  1. 3.   Tools and tactics to define specificity of metabolic chemical reporters
  2. Mukherjee, Mana Mohan; Bond, Michelle R; Abramowitz, Lara K; Biesbrock, Devin; Woodroofe, Carolyn C; Kim, Eun Ju; Swenson, Rolf E; Hanover, John A
  3. Frontiers in Molecular Biosciences. 2023, Dec 7; 10: 1286690.
  1. 4.   Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR
  2. Zong, Dali; Koussa, Natasha C; Cornwell, James A; Pankajam, Ajith V; Kruhlak, Michael J; Wong, Nancy; Chari,Raj; Cappell, Steven D; Nussenzweig, André
  3. Genes & Development. 2023, Nov 06; 37(19-20): 913-928.
  1. 5.   Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition
  2. Lai, Lick Pui; Brel, Viviane; Sharma, Kanika; Frappier, Julia; Le-Henanf, Nadia; Vivet, Bertrand; Muzet, Nicolas; Schell, Emilie; Morales, Renaud; Rooney, Eamonn; Basse, Nicolas; Yi,Ming; Lacroix, Frederic; Holderfield, Matthew; Englaro, Walter; Marcireau, Christophe; Debussche, Laurent; Nissley,Dwight; McCormick, Frank
  3. SLAS DISCOVERY. 2021, Apr 24; 26(7, SI): 922-932.
  1. 6.   Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
  2. Wheeler, David A; Takebe, Naoko; Hinoue, Toshinori; Hoadley, Katherine A; Cardenas, Maria F; Hamilton, Alina M; Laird, Peter W; Wang, Linghua; Johnson, Adrienne; Dewal, Ninad; Miller, Vincent; Piñeyro, David; Castro de Moura, Manuel; Esteller, Manel; Shen, Hui; Zenklusen, Jean Claude; Tarnuzzer, Roy; McShane, Lisa M; Tricoli, James V; Williams, Paul M; Lubensky, Irina; O'Sullivan-Coyne, Geraldine; Kohn, Elise C; Little, Richard F; White, Jeffrey; Malik, Shakun; Harris, Lyndsay; Weil, Carol; Chen, Alice P; Karlovich,Chris; Rodgers, Brian; Shankar, Lalitha; Jacobs, Paula; Nolan, Tracy; Hu, Jianhong; Muzny, Donna M; Doddapaneni, Harshavardhan; Korchina, Viktoriya; Gastier-Foster, Julie; Bowen, Jay; Leraas, Kristen; Edmondson,Elijah; Doroshow, James H; Conley, Barbara A; Ivy, S Percy; Staudt, Louis M
  3. Cancer Cell. 2021, Jan 11; 39(1): 38-53.e7.
  1. 7.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 8.   LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies
  2. O'Neill,Maura; Chan,King; Jaynes, Jesse M; Knotts, Zachary; Xu,Xia; Abisoye-Ogunniyan, Abisola; Guerin,Theresa; Schlomer,Jerome; Li, Dandan; Cary, Jeffrey W; Rajasekaran, Kanniah; Yates, Clayton; Kozlov,Serguei; Andresson,Thorkell; Rudloff, Udo
  3. Journal of pharmaceutical and biomedical analysis. 2020, Mar 20; 181: 113093.
  1. 9.   SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
  2. Deng,Xiang; Das, Shaoli; Valdez,Kristin; Camphausen, Kevin; Shankavaram, Uma
  3. Cancers. 2019, Nov; 11(11): pii: E1682.
  1. 10.   A Protocol for the Design of Protein and Peptide Nanostructure Self-Assemblies Exploiting Synthetic Amino Acids.
  2. Haspel, Nurit; Zheng, Jie; Aleman, Carlos; Zanuy, David; Nussinov, Ruth
  3. Methods in molecular biology (Clifton, N.J.). 2017 1529: 323-352.
  1. 11.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 12.   Topology of the disulfide bonds in the antiviral lectin scytovirin
  2. Moulaei, T.; Stuchlik, O.; Reed, M.; Yuan, W. R.; Pohl, J.; Lu, W. Y.; Haugh-Krumpe, L.; O'Keefe, B. R.; Wlodawer, A.
  3. Protein Science. 2010, Sep; 19(9): 1649-1661.
  1. 13.   Effects of Hapten Density on the Induced Antibody Repertoire
  2. Li, Q. A.; Rodriguez, L. G.; Farnsworth, D. F.; Gildersleeve, J. C.
  3. Chembiochem. 2010, Aug 16; 11(12): 1686-1691.
  1. 14.   Application of Halide Molten Salts as Novel Reaction Media for O-Glycosidic Bond Formation
  2. Kumar, V.; Talisman, I. J.; Malhotra, S. V.
  3. European Journal of Organic Chemistry. 2010, Jun; (18): 3377-3381.
  1. 15.   Nanoinformatics and DNA-Based Computing: Catalyzing Nanomedicine
  2. Maojo, V.; Martin-Sanchez, F.; Kulikowski, C.; Rodriguez-Paton, A.; Fritts, M.
  3. Pediatric Research. 2010, May; 67(5): 481-489.
  1. 16.   Proteomic analysis of scaffold proteins in the ERK cascade
  2. McKay, M. M.; Morrison, D. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 661: 323-34.
  1. 17.   Oligonucleotide recombination in Gram-negative bacteria
  2. Swingle, B.; Markel, E.; Costantino, N.; Bubunenko, M. G.; Cartinhour, S.; Court, D. L.
  3. Molecular Microbiology. 2010, Jan; 75(1): 138-148.
  1. 18.   Recent Development of Cyclic Amide (Pyridone/Lactam) Moiety Containing Heterocycles as Protein Kinase Inhibitors
  2. Wei, L. Y.; Malhotra, S. V.
  3. Current Medicinal Chemistry. 2010, Jan; 17(3): 234-253.
  1. 19.   Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine
  2. Klinman, D. M.; Yamamoto, M.; Tross, D.; Tomaru, K.
  3. Expert Opinion on Biological Therapy. 2009, Dec; 9(12): 1477-86.
  1. 20.   Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines
  2. Li, Q.; Anver, M. R.; Butcher, D. O.; Gildersleeve, J. C.
  3. Molecular Cancer Therapeutics. 2009 8(4): 971-979.
  1. 21.   Discovery and Characterization of a Peptide Motif That Specifically Recognizes a Non-native Conformation of Human IgG Induced by Acidic pH Conditions
  2. Sakamoto, K.; Ito, Y.; Hatanaka, T.; Soni, P. B.; Mori, T.; Sugimura, K.
  3. Journal of Biological Chemistry. 2009 284(15): 9986-9993.
  1. 22.   Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer
  2. Schneider, B. J.; Worden, F. P.; Gadgeel, S. M.; Parchment, R. E.; Hodges, C. M.; Zwiebel, J.; Dunn, R. L.; Wozniak, A. J.; Kraut, M. J.; Kalemkerian, G. P.
  3. Investigational New Drugs. 2009 27(6): 571-578.
  1. 23.   An engineered selenocysteine defines a unique class of antibody derivatives
  2. Hofer, T.; Thomas, J. D.; Burke, T. R.; Rader, C.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(34): 12451-12456.
  1. 24.   Testing beta-helix terminal coils stability by targeted substitutions with non-proteogenic amino acids: A molecular dynamics study
  2. Zanuy, D.; Rodriguez-Ropero, F.; Nussinov, R.; Aleman, C.
  3. Journal of Structural Biology. 2007, Nov; 160(2): 177-189.
  1. 25.   A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex
  2. Jacobs, A.; Quraishi, O.; Huang, X. C.; Bousquet-Gagnon, N.; Nault, G.; Francella, N.; Alvord, W. G.; Pham, N.; Soucy, C.; Robitaille, M.; Bridon, D.; Blumenthal, R.
  3. Journal of Biological Chemistry. 2007, Nov; 282(44): 32406-32413.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel